HIV-Tat protein forms phosphoinositide-dependent membrane pores implicated in unconventional protein secretion

Journal of Biological Chemistry

Volumn 290, Issue 36, 2015, Pages 21976-21984

  Zeitler, Marcel ^a   Steringer, Julia P ^a   Möller, Hans Michael ^a   Mayer, Matthias P ^a   Nickel, Walter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PORE SIZE; PROTEINS;

HIV TAT; MEMBRANE PORES; PHOSPHOINOSITIDES; PROTEIN SECRETION;

PHYSIOLOGY;

FIBROBLAST GROWTH FACTOR 2; LIPOSOME; MEMBRANE LIPID; OLIGOMER; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; TRANSACTIVATOR PROTEIN; LIPID BILAYER; PHOSPHATIDYLINOSITOL; PROTEIN BINDING;

ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE FORMATION; MEMBRANE PORE FORMATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN SECRETION; UNCONVENTIONAL PROTEIN SECRETION; CELL MEMBRANE; CHEMISTRY; GENETICS; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; VIROLOGY;

CELL MEMBRANE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLAST GROWTH FACTOR 2; HUMANS; LIPID BILAYERS; LIPOSOMES; MUTATION; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOLS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84941287105     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.667097     Document Type: Article

References (42)

1. Campbell, G. R., and Loret, E. P. (2009) What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 6, 50
2. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus Tat protein. J. Virol. 63, 1-8
3. Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., and Ensoli, B. (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-Associated heparan sulfate proteoglycans through its basic region. AIDS 11, 1421-1431
4. Debaisieux, S., Rayne, F., Yezid, H., and Beaumelle, B. (2012) The ins and outs of HIV-1 Tat. Traffic 13, 355-363
5. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55, 1189-1193
6. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261
7. Shi, B., Raina, J., Lorenzo, A., Busciglio, J., and Gabuzda, D. (1998) Neuronal apoptosis induced by HIV-1 Tat protein and TNF-: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4, 281-290
8. Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., and Jeang, K. T. (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. U.S.A. 97, 11466-11471
9. Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86
10. Nickel, W., and Rabouille, C. (2009) Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148-155
11. Rabouille, C., Malhotra, V., and Nickel, W. (2012) Diversity in unconventional protein secretion. J. Cell Sci. 125, 5251-5255
12. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287
13. Steringer, J. P., Möller, H. M., and Nickel, W. (2015) Unconventional secretion of fibroblast growth factor 2: A novel type of protein translocation across membranes? J. Mol. Biol. 427, 1202-1210
14. Rubartelli, A., Poggi, A., Sitia, R., and Zocchi, M. R. (1998) HIV-I Tat: A polypeptide for all seasons. Immunol. Today 19, 543-545
15. Bellino, S., Tripiciano, A., Picconi, O., Francavilla, V., Longo, O., Sgadari, C., Paniccia, G., Arancio, A., Angarano, G., Ladisa, N., Lazzarin, A., Tambussi, G., Nozza, S., Torti, C., Focà, E., Palamara, G., Latini, A., Sighinolfi, L., Mazzotta, F., Di Pietro, M., Di Perri, G., Bonora, S., Mercurio, V. S., Mussini, C., Gori, A., Galli, M., Monini, P., Cafaro, A., Ensoli, F., and Ensoli, B. (2014) The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study. Retrovirology 11, 49
16. Ensoli, B., Fiorelli, V., Ensoli, F., Cafaro, A., Titti, F., Buttò, S., Monini, P., Magnani, M., Caputo, A., and Garaci, E. (2006) Candidate HIV-1 Tat vaccine development: from basic science to clinical trials. AIDS 20, 2245-2261
17. Ensoli, F., Cafaro, A., Casabianca, A., Tripiciano, A., Bellino, S., Longo, O., Francavilla, V., Picconi, O., Sgadari, C., Moretti, S., Cossut, M. R., Arancio, A., Orlandi, C., Sernicola, L., Maggiorella, M. T., Paniccia, G., Mussini, C., Lazzarin, A., Sighinolfi, L., Palamara, G., Gori, A., Angarano, G., Di Pietro, M., Galli, M., Mercurio, V. S., Castelli, F., Di Perri, G., Monini, P., Magnani, M., Garaci, E., and Ensoli, B. (2015) HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. Retrovirology 12, 33
18. Rayne, F., Debaisieux, S., Bonhoure, A., and Beaumelle, B. (2010) HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol. Int. 34, 409-413
19. Rayne, F., Debaisieux, S., Yezid, H., Lin, Y. L., Mettling, C., Konate, K., Chazal, N., Arold, S. T., Pugnière, M., Sanchez, F., Bonhoure, A., Briant, L., Loret, E., Roy, C., and Beaumelle, B. (2010) Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J. 29, 1348-1362
20. Nickel, W., and Seedorf, M. (2008) Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 24, 287-308
21. Nickel, W. (2005) Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614
22. Schäfer, T., Zentgraf, H., Zehe, C., Brögger, B., Bernhagen, J., and Nickel, W. (2004) Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279, 6244-6251
23. Temmerman, K., Ebert, A. D., Möller, H. M., Sinning, I., Tews, I., and Nickel, W. (2008) A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9, 1204-1217
24. Temmerman, K., and Nickel, W. (2009) A novel flow cytometric assay to quantify interactions between proteins and membrane lipids. J. Lipid Res. 50, 1245-1254
25. Zacherl, S., La Venuta, G., Möller, H. M., Wegehingel, S., Dimou, E., Sehr, P., Lewis, J. D., Erfle, H., Pepperkok, R., and Nickel, W. (2015) A direct role for ATP1A1 in unconventional secretion of fibroblast growth factor 2. J. Biol. Chem. 290, 3654-3665
26. Möller, H. M., Steringer, J. P., Wegehingel, S., Bleicken, S., Mönster, M., Dimou, E., Unger, S., Weidmann, G., Andreas, H., García-Sáez, A. J., Wild, K., Sinning, I., and Nickel, W. (2015) Formation of disulfide bridges drives oligomerization, membrane pore formation and translocation of fibroblast growth factor 2 to cell surfaces. J. Biol. Chem. 290, 8925-8937
27. Backhaus, R., Zehe, C., Wegehingel, S., Kehlenbach, A., Schwappach, B., and Nickel, W. (2004) Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J. Cell Sci. 117, 1727-1736
28. Torrado, L. C., Temmerman, K., Möller, H. M., Mayer, M. P., Seelenmeyer, C., Backhaus, R., and Nickel, W. (2009) An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation. J. Cell Sci. 122, 3322-3329
29. Steringer, J. P., Bleicken, S., Andreas, H., Zacherl, S., Laussmann, M., Temmerman, K., Contreras, F. X., Bharat, T. A., Lechner, J., Möller, H. M., Briggs, J. A., García-Sáez, A. J., and Nickel, W. (2012) Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)-dependent oligomerization of fibroblast growth factor 2 (FGF2) triggers the formation of a lipidic membrane pore implicated in unconventional secretion. J. Biol. Chem. 287, 27659-27669
30. Nickel, W. (2011) The unconventional secretory machinery of fibroblast growth factor 2. Traffic 12, 799-805
31. Ebert, A. D., Laussmann, M., Wegehingel, S., Kaderali, L., Erfle, H., Reichert, J., Lechner, J., Beer, H. D., Pepperkok, R., and Nickel, W. (2010) Teckinase-mediated phosphorylation of fibroblast growth factor 2 is essential for unconventional secretion. Traffic 11, 813-826
32. Nickel, W. (2007) Unconventional secretion: An extracellular trap for export of fibroblast growth factor 2. J. Cell Sci. 120, 2295-2299
33. Zehe, C., Engling, A., Wegehingel, S., Schäfer, T., and Nickel, W. (2006) Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc. Natl. Acad. Sci. U.S.A. 103, 15479-15484
34. Shojania, S., Henry, G. D., Chen, V. C., Vo, T. N., Perreault, H., and O'Neil, J. D. (2010) High yield expression and purification of HIV-1 Tat1-72 for structural studies. J. Virol. Methods 164, 35-42
35. Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Söllner, T. H., and Rothman, J. E. (1998) SNAREpins: minimal machinery for membrane fusion. Cell 92, 759-772
36. Engling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S., and Nickel, W. (2002) Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J. Cell Sci. 115, 3619-3631
37. Barth, A. (2007) Infrared spectroscopy of proteins. Biochim. Biophys. Acta 1767, 1073-1101
38. Milosevic, I., Sørensen, J. B., Lang, T., Krauss, M., Nagy, G., Haucke, V., Jahn, R., and Neher, E. (2005) Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells. J. Neurosci. 25, 2557-2565
39. Malsam, J., Seiler, F., Schollmeier, Y., Rusu, P., Krause, J. M., and Söllner, T. H. (2009) The carboxy-Terminal domain of complexin I stimulates liposome fusion. Proc. Natl. Acad. Sci. U.S.A. 106, 2001-2006
40. Peloponese, J. M., Jr., Gregoire, C., Opi, S., Esquieu, D., Sturgis, J., Lebrun, E., Meurs, E., Collette, Y., Olive, D., Aubertin, A. M., Witvrow, M., Pannecouque, C., De Clercq, E., Bailly, C., Lebreton, J., and Loret, E. P. (2000) 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie 323, 883-894
41. Shojania, S., and O'Neil, J. D. (2006) HIV-1 Tat is a natively unfolded protein: The solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J. Biol. Chem. 281, 8347-8356
42. Bayer, P., Kraft, M., Ejchart, A., Westendorp, M., Frank, R., and Rösch, P. (1995) Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247, 529-535